
|Videos|April 1, 2022
Impact of Long-Acting HIV Prevention Drugs
A panel of experts discuss the role of PrEP in HIV prevention with a focus on current and newly approved options.
Advertisement
Episodes in this series

Now Playing
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
mRNA COVID-19 Booster Outperforms Protein-Based Shot on Antibodies, But Both Cut Infections Over 12 Months
2
Navigating REMS: Challenges, Perspectives, and the Path Forward for Bispecific Antibody Programs
3
FDA Approves Zidesamtinib for Previously Treated ROS1-Positive NSCLC
4
Building a Pharmacist-Led Furoscix Workflow From Scratch
5
































































































